Identification of an immune signature to predict poor clinical outcome in cervical cancer

References

• Siegel RL , MillerKD , JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Cain JM , HowettMK. Preventing cervical cancer. Science288(5472), 1753–1755 (2000).
   PubMed Web of Science ®Google Scholar
• Cohen PA , JhingranA , OakninA , DennyL. Cervical cancer. Lancet393(10167), 169–182 (2019).
   PubMed Web of Science ®Google Scholar
• Chopra S , GuptaM , MathewAet al. Locally advanced cervical cancer: a study of 5-year outcomes. Indian J. Cancer55(1), 45–49 (2018).
   PubMed Web of Science ®Google Scholar
• Schachter J , RibasA , LongGVet al. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label Phase III study (KEYNOTE-006). Lancet390(10105), 1853–1862 (2017).
   PubMed Web of Science ®Google Scholar
• Herbst RS , BaasP , Perez-GraciaJLet al. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Ann. Oncol.30(2), 281–289 (2019).
   PubMed Web of Science ®Google Scholar
• Blank CU , RozemanEA , FanchiLFet al. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat. Med.24(11), 1655–1661 (2018).
   PubMed Web of Science ®Google Scholar
• Chung HC , RosW , DelordJPet al. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the Phase II KEYNOTE-158 study. J. Clin. Oncol.37(17), 1470–1478 (2019).
   PubMed Web of Science ®Google Scholar
• Li X , WangJ , ZhangCet al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J. Pathol.246(2), 166–179 (2018).
   PubMed Web of Science ®Google Scholar
• Cui JH , LinKR , YuanSHet al. TCR repertoire as a novel indicator for immune monitoring and prognosis assessment of patients with cervical cancer. Front Immunol.9, 2729 (2018).
   PubMed Web of Science ®Google Scholar
• Heeren AM , KosterBD , SamuelsSet al. High and interrelated rates of PD-L1 + CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer. Cancer Immunol. Res.3(1), 48–58 (2015).
   PubMed Web of Science ®Google Scholar
• Savas P , VirassamyB , YeCet al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat. Med.24(7), 986–993 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang Q , HeY , LuoNet al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell179(4), 829–845, e820 (2019).
   PubMed Web of Science ®Google Scholar
• Meng S , ZhouH , FengZet al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol. Cancer16(1), 94 (2017).
   PubMed Web of Science ®Google Scholar
• Vincent HA , DeutscherMP. Substrate recognition and catalysis by the exoribonuclease RNase R. J. Biol. Chem.281(40), 29769–29775 (2006).
   PubMed Web of Science ®Google Scholar
• Jeck WR , SorrentinoJA , WangKet al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA19(2), 141–157 (2013).
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A , StottmeisterC , GlazarPet al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell.58(5), 870–885 (2015).
   PubMed Web of Science ®Google Scholar
• Yang Y , GaoX , ZhangMet al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J. Natl Cancer Inst.110(3), 304–315 (2018).
   PubMedGoogle Scholar
• Zhang PF , PeiX , LiKSet al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol. Cancer18(1), 179 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang PF , WeiCY , HuangXYet al. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Mol. Cancer18(1), 105 (2019).
   PubMedGoogle Scholar
• Barrett T , WilhiteSE , LedouxPet al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res.41(Database issue), D991–D995 (2013).
   PubMed Web of Science ®Google Scholar
• Ritchie ME , PhipsonB , WuDet al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res.43(7), e47 (2015).
   PubMed Web of Science ®Google Scholar
• Yoshihara K , ShahmoradgoliM , MartinezEet al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun.4, 2612 (2013).
   PubMed Web of Science ®Google Scholar
• Charoentong P , FinotelloF , AngelovaMet al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep.18(1), 248–262 (2017).
   PubMed Web of Science ®Google Scholar
• Robinson DR , WuYM , LonigroRJet al. Integrative clinical genomics of metastatic cancer. Nature548(7667), 297–303 (2017).
   PubMed Web of Science ®Google Scholar
• Mermel CH , SchumacherSE , HillB , MeyersonML , BeroukhimR , GetzG. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol.12(4), R41 (2011).
   PubMed Web of Science ®Google Scholar
• Reich M , LiefeldT , GouldJ , LernerJ , TamayoP , MesirovJP. GenePattern 2.0. Nat. Genet.38(5), 500–501 (2006).
   PubMed Web of Science ®Google Scholar
• Wei Y , ChenX , LiangCet al. A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology71(1), 130–147 (2020).
   PubMed Web of Science ®Google Scholar
• Gao J , AksoyBA , DogrusozUet al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal.6(269), pl1 (2013).
   PubMed Web of Science ®Google Scholar
• Lim S , PhillipsJB , MadeiraDa Silva Let al. Interplay between immune checkpoint proteins and cellular metabolism. Cancer Res.77(6), 1245–1249 (2017).
   PubMed Web of Science ®Google Scholar
• Vo JN , CieslikM , ZhangYet al. The landscape of circular RNA in cancer. Cell176(4), 869–881, e813 (2019).
   PubMed Web of Science ®Google Scholar
• Gandhi L , Rodriguez-AbreuD , GadgeelSet al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med.378(22), 2078–2092 (2018).
   PubMed Web of Science ®Google Scholar
• Wang W , GreenM , ChoiJEet al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature569(7755), 270–274 (2019).
   PubMed Web of Science ®Google Scholar
• Di Pilato M , KimEY , CadilhaBLet al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature570(7759), 112–116 (2019).
   PubMed Web of Science ®Google Scholar
• Brooks RA , FlemingGF , LastraRRet al. Current recommendations and recent progress in endometrial cancer. CA Cancer J. Clin.69(4), 258–279 (2019).
   PubMed Web of Science ®Google Scholar
• Cristescu R , MoggR , AyersMet al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science362(6411), eaar3593 (2018).
   PubMed Web of Science ®Google Scholar
• Mariathasan S , TurleySJ , NicklesDet al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature554(7693), 544–548 (2018).
   PubMed Web of Science ®Google Scholar
• Liu J , NieS , WuZet al. Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment. Genomics112(5), 3117–3134 (2020).
   PubMed Web of Science ®Google Scholar
• Jansen CS , ProkhnevskaN , MasterVAet al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature576(7787), 465–470 (2019).
   PubMed Web of Science ®Google Scholar
• Petrelli F , GhidiniM , GhidiniA , TomaselloG. Outcomes following immune checkpoint inhibitor treatment of patients with microsatellite instability-high cancers: a systematic review and meta-analysis. JAMA Oncol.6(7), 1068–1071 (2020).
   PubMed Web of Science ®Google Scholar
• Liu L , BaiX , WangJet al. Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer. Clin. Cancer Res.25(24), 7413–7423 (2019).
   PubMed Web of Science ®Google Scholar
• Samstein RM , LeeCH , ShoushtariANet al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet.51(2), 202–206 (2019).
   PubMed Web of Science ®Google Scholar
• Chen Z , MouL , PanY , FengC , ZhangJ , LiJ. CXCL8 promotes glioma progression by activating the JAK/STAT1/HIF-1alpha/snail signaling axis. Onco Targets Ther.12, 8125–8138 (2019).
   PubMed Web of Science ®Google Scholar
• Xiao YC , YangZB , ChengXSet al. CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Lett.361(1), 22–32 (2015).
   PubMed Web of Science ®Google Scholar
• Lin C , HeH , LiuHet al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut68(10), 1764–1773 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhouL , GuXet al. CXCL8(high) inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression. Immunol. Cell Biol.98(8), 682–692 (2020).
   PubMed Web of Science ®Google Scholar
• Song Y , YangJM. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer. Biochem. Biophys. Res. Commun.493(1), 1–8 (2017).
   PubMed Web of Science ®Google Scholar
• Ferreira N , MesquitaI , BaltazarF , SilvestreR , GranjaS. IL-17A and IL-17F orchestrate macrophages to promote lung cancer. Cell. Oncol.43(4), 643–654 (2020).
   Web of Science ®Google Scholar
• Salazar Y , ZhengX , BrunnDet al. Microenvironmental Th9- and Th17-lymphocytes induce metastatic spreading in lung cancer. J. Clin. Invest.130(7), 3560–3575 (2020).
   PubMed Web of Science ®Google Scholar